NCT05160922 2026-03-30
Crizotinib Continuation Clinical Study
Pfizer
Phase 4 Active not recruiting
Clinical Trials
3 trialsNCT01524926 2023-12-11
CREATE
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Completed
NCT03874273 2019-03-14
Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 2/3 Unknown